GPT HEALTHCARE LIMITED Fair Value
GPTHEALTH · Healthcare · Current price ₹151.78
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹37 | 16% ROE fading to 13% over ~10 yrs, on ₹33 book |
| Relative P/E | ₹333 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹62 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹136 | Street consensus 12-month target price |
Is GPT HEALTHCARE LIMITED undervalued?
DocStoX estimates the fair value of GPT HEALTHCARE LIMITED at ₹126 per share, versus the current market price of ₹152. That puts the stock about -16.8% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹37), Relative P/E (₹333), Graham floor (₹62), Analyst target (₹136). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹37 (bear) to ₹126 (base) to ₹333 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on GPT HEALTHCARE LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.